12:00 AM
 | 
Mar 23, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

14-type high-risk HPV test regulatory update

FDA approved a PMA from Hologic for its Cervista HPV HR test to detect 14 high-risk types of human papillomavirus (HPV) infection in women...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >